Organization
Seattle Genetics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Seattle Genetics, Inc.
... Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc, F. Hoffmann-La Roche AG, Eli Lilly, Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc., Celgene Corporation are some notable companies vying for ...
... protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seattle Genetics' proprietary technology. The ADC employs a linker system that is designed ...
... Inc. (NYSE:GRUB), Patterson Companies, Inc. (NASDAQ:PDCO), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), and Seattle Genetics, Inc. (NASDAQ:SGEN) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified ...
... Seattle Genetics, Inc. = 20 percent) were: anemia, peripheral sensory neuropathy, nausea, diarrhea, fatigue ...
... Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko ...
... in Phase III ALCYONE study of daratumumab in front line multiple myeloma Seattle Genetics exercised its option to co-develop tisotumab vedotin with Genmab "This past ...
... for the first time during the Plenary Scientific Session in partnership with Seattle Genetics. Topline data from ECHELON-1, which was reported in June 2017, demonstrated ...
... If you want a Stock Review on KURA, PGNX, REGN, or SGEN then come over tohttp://dailystocktracker.com/register/and sign up for your free customized report. For ...
... for the first time during the Plenary Scientific Session in partnership with Seattle Genetics. Topline data from ECHELON-1, which was reported in June 2017, demonstrated ...
... Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that 18 abstracts featuring data from the broad ...
... Seattle Genetics, Inc. (NASDAQ: SGEN) today reported financial results for the third quarter and nine ...
... hiring now GoDaddy promoted 30% more women this year (& they're hiring) Seattle Genetics Rating: 3.7 What they do: "Seattle Genetics is the industry leader ...
... Seattle Genetics, Inc. (NASDAQ: SGEN) today announced two clinical collaboration agreements for the evaluation of ...
... Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko ...
... Washington; October 10, 2017 Genmab A/S (Nasdaq Copenhagen: GEN) and Seattle Genetics, Inc. (NASDAQ: SGEN) announced today a decision to start a Phase II study ...
... Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its third quarter financial ...
... Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that the U.S. Food and Drug Administration (FDA) ...
... If you want a Stock Review on PBYI, REGN, SRPT, or SGEN then come over to http://dailystocktracker.com/register/and sign up for your free customized report ...
... Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that preliminary clinical data for tisotumab vedotin from ...
... lengthening list of senior biotech figures including Biogen head Michel Vounatsos and Seattle Genetics' Clay Siegall, Ph.D.—the group tells the president that the young people ...
... agonist, which emerged from AbbVie’s work with French biotech Inventiva. Protocol > Seattle Genetics exercised its option to co-develop tisotumab vedotin with Genmab. The Danish ...
... Genmab A/S (Nasdaq Copenhagen: GEN) and Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that Seattle Genetics, Inc. has exercised its option ...
... will also be the first program under Unum's global collaboration with Seattle Genetics (Nasdaq: SGEN) to enter clinical development, and Unum's third clinical trial with ...
... representing the excess of fair value of the warrant issued to Seattle Genetics, Inc. on February 10, 2017 (the "SGEN Warrant") over the proceeds received ...
... Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that the U.S. Food and Drug Administration (FDA) ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤